L'Amar Lifesciences & Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 31-12-2024
- Paid Up Capital ₹ 0.10 M
as on 31-12-2024
- Company Age 21 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -39.01%
(FY 2015)
- Profit -514.12%
(FY 2015)
- Ebitda -2270.79%
(FY 2015)
- Net Worth -16.93%
(FY 2015)
- Total Assets -16.39%
(FY 2015)
About L'Amar Lifesciences & Biotech
The Corporate was formerly known as Ananya Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shailesh Patel, Shonaal Lulla, and Geeta Lulla serve as directors at the Company.
- CIN/LLPIN
U24100MH2004PTC144020
- Company No.
144020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at L'Amar Lifesciences & Biotech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shailesh Patel  | Director | 29-Aug-2018 | Current |
| Shonaal Lulla | Director | 16-Jan-2004 | Current |
| Geeta Lulla | Director | 06-Sep-2012 | Current |
Financial Performance of L'Amar Lifesciences & Biotech.
Ananya Lifescience Private Limited, for the financial year ended 2015, experienced significant reduction in revenue, with a 39.01% decrease. The company also saw a substantial fall in profitability, with a 514.12% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of L'Amar Lifesciences & Biotech?
In 2017, L'Amar Lifesciences & Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
L'amar Natural Product Private LimitedActive 29 years 7 monthsShailesh Patel, Shonaal Lulla and 1 more are mutual person
Amar-Deep Pharmas LlpActive 13 years 8 monthsShailesh Patel, Shonaal Lulla and 1 more are mutual person
- Renaissance Lifesciences India LlpActive 13 years 6 months
Shailesh Patel, Shonaal Lulla and 1 more are mutual person
- Fantastic Medicines Private LimitedActive 28 years 7 months
Shailesh Patel, Shonaal Lulla and 1 more are mutual person
- Forest Gold Products Private LimitedActive 24 years 9 months
Shailesh Patel, Shonaal Lulla and 1 more are mutual person
- L'amar Exportz Private LimitedActive 27 years 5 months
Shailesh Patel, Shonaal Lulla and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at L'Amar Lifesciences & Biotech?
Unlock and access historical data on people associated with L'Amar Lifesciences & Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of L'Amar Lifesciences & Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped L'Amar Lifesciences & Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
